Additionally, in the YAP-silenced group, tumor cell apoptosis was decreased following treatment with trastuzumab, and the levels of cleaved caspase-3 and PARP expression were significantly decreased (Fig. 2C). The gene discussed is CASP3; the disease is neoplasm.